首页 | 本学科首页   官方微博 | 高级检索  
     

白三烯受体拮抗剂治疗咳嗽变异性哮喘临床观察
引用本文:杨臻. 白三烯受体拮抗剂治疗咳嗽变异性哮喘临床观察[J]. 中国医药导报, 2011, 8(1): 76-77
作者姓名:杨臻
作者单位:河南省郑州市中心医院儿科,河南,郑州,450007
摘    要:目的:探讨白三烯受体拈抗剂治疗咳嗽变异性哮喘临床疗效。方法:将2008年4月-2010年4月门诊收治的312例咳嗽变异性哮喘儿童分为激素吸入组152例,白三烯受体拈抗组160例,观察两组临床症状缓解时间、复发情况、临床疗效评价。结果:两组总有效率比较,差异有统计学意义(P〈0.05);两组临床症状缓解时间、复发情况比较,差异无统计学意义(P〉0.05)。结论:白三烯受体拈抗剂治疗咳嗽变异性哮喘临床疗效确切,改善控制症状明显,可防止复发,副作用小,顺应性良好。

关 键 词:白三烯受体桔抗剂  咳嗽变异性哮喘  临床观察

Clinical observation of leukotriene receptor antagonist in the treatment of cough variant asthma
YANG Zhen. Clinical observation of leukotriene receptor antagonist in the treatment of cough variant asthma[J]. China Medical Herald, 2011, 8(1): 76-77
Authors:YANG Zhen
Affiliation:YANG Zhen (Department of Pediatrics,the Center Hospital of Zhengzhou City,He′nan Province,Zhengzhou 450007,China)
Abstract:Objective: To investigate clinical efficacy of leukotriene receptor antagonist in the treatment of cough variant asthma.Methods: From April 2008 to April 2010 312 cases of out-patient children with cough variant asthma were selected and divided into hormone inhalation group(152 cases) and leukotriene receptor antagonist group(160 cases),relief time of clinical symptom and recurrence were observed,clinical efficacy was evaluated.Results: The total effective rate had significant difference between two groups(...
Keywords:Leukotriene receptor antagonist  Cough variant asthma  Clinical observation  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号